Goldman Sachs Group Inc Ardelyx, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,369,852 shares of ARDX stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,369,852
Previous 2,921,663 18.89%
Holding current value
$11.9 Million
Previous $21.6 Million 24.58%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.28 - $7.57 $2.91 Million - $4.18 Million
-551,811 Reduced 18.89%
2,369,852 $16.3 Million
Q2 2024

Aug 13, 2024
BUY
$5.89 - $9.31 $5.48 Million - $8.66 Million
930,185 Added 46.71%
2,921,663 $21.6 Million
Q1 2024

May 15, 2024
BUY
$6.05 - $9.74 $5.37 Million - $8.64 Million
887,408 Added 80.38%
1,991,478 $14.5 Million
Q4 2023

Feb 13, 2024
SELL
$3.29 - $6.64 $542,234 - $1.09 Million
-164,813 Reduced 12.99%
1,104,070 $6.85 Million
Q3 2023

May 14, 2024
BUY
$3.3 - $4.83 $543,882 - $796,046
164,813 Added 14.93%
1,268,883 $5.18 Million
Q3 2023

Nov 14, 2023
SELL
$3.3 - $4.83 $441,675 - $646,452
-133,841 Reduced 9.54%
1,268,883 $5.18 Million
Q2 2023

May 14, 2024
SELL
$3.23 - $4.95 $827,726 - $1.27 Million
-256,262 Reduced 15.45%
1,402,724 $4.76 Million
Q2 2023

Aug 14, 2023
SELL
$3.23 - $4.95 $827,726 - $1.27 Million
-256,262 Reduced 15.45%
1,402,724 $4.76 Million
Q1 2023

May 14, 2024
BUY
$2.68 - $4.79 $3.4 Million - $6.07 Million
1,266,814 Added 323.03%
1,658,986 $7.95 Million
Q1 2023

May 11, 2023
BUY
$2.68 - $4.79 $3.4 Million - $6.07 Million
1,266,814 Added 323.03%
1,658,986 $7.95 Million
Q4 2022

May 14, 2024
BUY
$1.22 - $2.85 $458,862 - $1.07 Million
376,117 Added 2342.68%
392,172 $1.12 Million
Q4 2022

Feb 13, 2023
BUY
$1.22 - $2.85 $458,862 - $1.07 Million
376,117 Added 2342.68%
392,172 $1.12 Million
Q3 2022

May 14, 2024
SELL
$0.59 - $1.44 $187,772 - $458,291
-318,258 Reduced 95.2%
16,055 $19,000
Q3 2022

Nov 10, 2022
SELL
$0.59 - $1.44 $187,772 - $458,291
-318,258 Reduced 95.2%
16,055 $0
Q2 2022

May 14, 2024
SELL
$0.51 - $1.17 $392,576 - $900,615
-769,757 Reduced 69.72%
334,313 $198,000
Q2 2022

Aug 15, 2022
BUY
$0.51 - $1.17 $31,587 - $72,466
61,937 Added 22.74%
334,313 $198,000
Q1 2022

May 16, 2022
SELL
$0.65 - $1.18 $217,149 - $394,209
-334,076 Reduced 55.09%
272,376 $291,000
Q4 2021

Feb 14, 2022
BUY
$0.86 - $1.7 $65,599 - $129,674
76,279 Added 14.39%
606,452 $667,000
Q3 2021

Nov 10, 2021
BUY
$1.27 - $8.17 $673,319 - $4.33 Million
530,173 New
530,173 $700,000

Others Institutions Holding ARDX

# of Institutions
215
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $775M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email